Evidence map›Paper›PMID 35325061›Full record

ArticleCardiovascular research2023

Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.

Sean M Davidson, Chantal M Boulanger, Elena Aikawa, Lina Badimon, Lucio Barile, Christoph J Binder, Alain Brisson, Edit Buzas, Costanza Emanueli, Felix Jansen and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 153 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. EV-Encapsulated Mitochondrial miRNAs: Enhancing Cardiomyocyte Bioenergetics.International journal of molecular sciences · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 18 institutions in 10 countries.

Sean M DavidsonThe Hatter Cardiovascular Institute, University College London, WC1E 6HX London, UK.ORCID 0000-0001-5182-4980
Chantal M BoulangerUniversité Paris Cité, Paris-Cardiovascular Research Center, INSERM, Paris, France.ORCID 0000-0002-3687-651X
Elena AikawaDepartment of Medicine, Center for Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-7835-2135
Lina BadimonCardiovascular Science Program-ICCC, IR-Hospital de la Santa Creu i Santa Pau-IIBSantPau, CiberCV, Autonomous University of Barcelona, Barcelona, Spain.ORCID 0000-0002-9162-2459
Lucio BarileLaboratory for Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale and Faculty of Biomedical Sciences, Università Svizzera italiana, 6900 Lugano, Switzerland.ORCID 0000-0002-5827-0439
Christoph J BinderDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-8313-7050
Alain BrissonMolecular Imaging and NanoBioTechnology, UMR-5248-CBMN, CNRS-University of Bordeaux-IPB, Bat. B14, Allée Geoffroy Saint-Hilaire, 33600 Pessac, France.ORCID 0000-0003-0342-352X
Edit BuzasDepartment of Genetics, Cell- and Immunobiology, Semmelweis University, HCEMM-SU and ELKH-SE Immune Proteogenomics Extracellular Vesicle Research Group, Budapest, Hungary.ORCID 0000-0002-3744-206X
Costanza EmanueliNational Heart and Lung Institute, Imperial College London, Hammersmith Campus, London W12 0NN, UK.ORCID 0000-0002-2392-0702
Felix JansenDepartment of Internal Medicine II, Heart Center, University Hospital Bonn, Bonn, Germany.ORCID 0000-0001-6962-5330
Miroslava KatsurThe Hatter Cardiovascular Institute, University College London, WC1E 6HX London, UK.ORCID 0000-0001-7704-0228
Romaric LacroixAix Marseille University, INSERM 1263, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Centre de Recherche en CardioVasculaire et Nutrition (C2VN), Marseille, France.ORCID 0000-0002-5756-470X
Sai Kiang LimInstitute of Medical Biology and Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.ORCID 0000-0002-5752-3297
Nigel MackmanDepartment of Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-9170-7700
Manuel MayrKing's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.ORCID 0000-0002-0597-829X
Philippe MenaschéDepartment of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Paris, France.ORCID 0000-0002-9845-4064
Rienk NieuwlandVesicle Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-5671-3400
Susmita SahooCardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-7279-1564
Kaloyan TakovKing's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.ORCID 0000-0002-8642-6306
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4360-1511
Pieter VaderUniversité Paris Cité, Paris-Cardiovascular Research Center, INSERM, Paris, France.ORCID 0000-0002-7059-8920
Marca H M WaubenFaculty of Veterinary Medicine, Department of Biomolecular Health Sciences, Utrecht University, Yalelaan 2, Utrecht, The Netherlands.ORCID 0000-0003-0360-0311
Kenneth WitwerDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-1664-4233
Joost P G SluijterLaboratory of Experimental Cardiology, Department of Cardiology, UMC Utrecht Regenerative Medicine Center and Circulatory Health Laboratory, Utrecht University, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-2088-9102
Inserm · FRUtrecht University · NLKing's College London · GBUniversity College London · GBAgency for Science, Technology and Research · SGAmsterdam University Medical Centers · NLBrigham and Women's Hospital · USCentre National de la Recherche Scientifique · FREnte Ospedaliero Cantonale · CHHammersmith Hospital · GBIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USMedical University of Vienna · ATMedizinische Hochschule Hannover · DESemmelweis University · HUUniversitat Autònoma de Barcelona · ESUniversity Hospital Bonn · DEUniversity of North Carolina at Chapel Hill · US

Funding

Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIVR01AI144997 · NIAID · JOHNS HOPKINS UNIVERSITY · PI RAMRATNAM, BHARAT, WITWER, KENNETH W · 2019 to 2023
$4.0M
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette UseR01DA047807 · NIDA · JOHNS HOPKINS UNIVERSITY · PI WITWER, KENNETH W · 2018 to 2022
$3.7M
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular VesiclesR33MH118164 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MACHAIRAKI, VASILIKI, WITWER, KENNETH W · 2020 to 2022
$2.2M
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein AggregatesUH3CA241694 · NCI · JOHNS HOPKINS UNIVERSITY · PI WITWER, KENNETH W · 2021 to 2022
$1.1M
British Heart Foundation CH/15/1/31199British Heart Foundation CH/16/3/32406British Heart Foundation FS/PHD/22/29237British Heart Foundation PG/18/44/33790British Heart Foundation PG/21/10798British Heart Foundation RG/20/9/35101British Heart Foundation RG/F/21/110053NCI NIH HHS UH3 CA241694NIAID NIH HHS R01 AI144997NIDA NIH HHS R01 DA047807NIMH NIH HHS R33 MH118164
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are nanosized vesicles with a lipid bilayer that are released from cells of the cardiovascular system, and are considered important mediators of intercellular and extracellular communications. Two types of EVs of particular interest are exosomes and microvesicles, which have been identified in all tissue and body fluids and carry a variety of molecules including RNAs, proteins, and lipids. EVs have potential for use in the diagnosis and prognosis of cardiovascular diseases and as new therapeutic agents, particularly in the setting of myocardial infarction and heart failure. Despite their promise, technical challenges related to their small size make it challenging to accurately identify and characterize them, and to study EV-mediated processes. Here, we aim to provide the reader with an overview of the techniques and technologies available for the separation and characterization of EVs from different sources. Methods for determining the protein, RNA, and lipid content of EVs are discussed. The aim of this document is to provide guidance on critical methodological issues and highlight key points for consideration for the investigation of EVs in cardiovascular studies.

Indexed as

Cardiovascular SystemCell-Derived MicroparticlesExosomesExtracellular VesiclesMyocardial InfarctionHumansRNARNABiodistributionBloodCardiovascular diseasesExosomesExtracellular vesicle compositionHeartMicrovesiclesTherapeutics

Identifiers

PMID35325061
PMCPMC10233250
OpenAlexW4220972537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.